MAATMaaT PharmaMAAT info
$7.94info-2.19%24h
Global rank21697
Market cap$91.86M
Change 7d-0.56%
YTD Performance2.29%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    MaaT Pharma (MAAT) Stock Overview

    MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. Its products pipeline includes MaaT013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials to treat melanoma; MaaT033, which is in phase 1b clinical trials for the improvement of survival in patients with acute myeloid leukemia or other liquid tumors receiving allogeneic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors. The company was incorporated in 2014 and is headquartered in Lyon, France.

    MAAT Stock Information

    Symbol
    MAAT
    Address
    70 Avenue Tony GarnierLyon, 69007France
    Founded
    -
    Trading hours
    -
    Website
    https://www.maatpharma.com
    Country
    πŸ‡«πŸ‡· France
    Phone Number
    33 4 28 29 14 00

    MaaT Pharma (MAAT) Price Chart

    -
    Value:-

    MaaT Pharma Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $7.94
    N/A
    Market Cap
    $91.86M
    N/A
    Shares Outstanding
    11.57M
    N/A
    Employees
    51.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org